Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial

Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial

Undifferentiated febrile illness (UFI) includes typhoid and typhus fevers and generally designates fever without any localizing signs. UFI is a great therapeutic challenge in countries like Nepal because of the lack of available point-of-care, rapid diagnostic tests. Often patients are empirically t...

Full description

Bibliographic Details
Main Authors:	Pokharel, S, Basnyat, B, Arjyal, A, Mahat, S, Kc, R, Bhuju, A, Poudyal, B, Kestelyn, E, Shrestha, R, Phuong, D, Thapa, R, Karki, M, Dongol, S, Karkey, A, Wolbers, M, Baker, S, Thwaites, G
Format:	Journal article
Language:	English
Published:	BioMed Central 2017

Similar Items

Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial
by: Sunil Pokharel, et al.
Published: (2017-10-01)

Trimethoprim-sulfamethoxazole (SXT) versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: a double-blind, randomized, placebo-controlled trial
by: Giri, A, et al.
Published: (2020)

The emergence of azithromycin-resistant Salmonella Typhi in Nepal
by: Duy, PT, et al.
Published: (2020)

Azithromycin and cefixime combination versus azithromycin alone for the out-patient treatment of clinically suspected or confirmed uncomplicated typhoid fever in South Asia: a randomised controlled trial protocol
by: Giri, A, et al.
Published: (2021)

Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01)

Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.
by: Koirala, K, et al.
Published: (2012)

CO-TRIMOXAZOLE AND BLOOD
by: Fleming, A, et al.
Published: (1974)

Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal
by: Dongol, S, et al.
Published: (2021)

Letter: Co-trimoxazole and the blood.
by: Fleming, A, et al.
Published: (1974)

The impact of migration and antimicrobial resistance on the transmission dynamics of typhoid fever in Kathmandu, Nepal: A mathematical modelling study.
by: Saad, N, et al.
Published: (2017)

Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2092 participants enrolled into 4 randomized, controlled trials in Nepal
by: Thompson, C, et al.
Published: (2017)

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption
by: Pouwels, K, et al.
Published: (2017)

Acute polyneuropathy possibily associated with co-trimoxazole.
by: Grossman, AB, et al.
Published: (1977)

Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever
by: Näsström, E, et al.
Published: (2014)

The expanding role of co-trimoxazole in developing countries.
by: Church, J, et al.
Published: (2014)

The expanding role of co-trimoxazole in developing countries.
by: Church, J, et al.
Published: (2015)

Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.
by: Parry, C, et al.
Published: (2015)

Dengue and COVID-19: Managing Undifferentiated Febrile Illness during a “Twindemic”
by: Liang En Wee, et al.
Published: (2022-05-01)

Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases
by: Blohmke, CJ, et al.
Published: (2019)

Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis
by: MRH Roushan, et al.
Published: (2004-09-01)

Diagnostic host gene signature to accurately distinguish enteric fever from other febrile diseases
by: Blohmke, CJ, et al.
Published: (2019)

Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
by: Gibb, D, et al.
Published: (2005)

Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial
by: Koirala, S, et al.
Published: (2013)

Tuberculosis in staff and students of Patan Hospital
by: Shrestha, P, et al.
Published: (2018)

A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes
by: Manandhar, S, et al.
Published: (2020)

Incidence of acute undifferentiated febrile illnesses in an urban slum of Delhi: A longitudinal cohort study
by: Debadatta Nayak, et al.
Published: (2024-03-01)

Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.
by: Arjyal, A, et al.
Published: (2016)

Fatal acute undifferentiated febrile illness among clinically suspected leptospirosis cases in Colombia, 2016-2019.
by: Eliana L Parra Barrera, et al.
Published: (2023-10-01)

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
by: Bwakura-Dangarembizi, M, et al.
Published: (2014)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
by: Hasse, B, et al.
Published: (2014)

Tubo-ovarian abscess infected by Salmonella typhi.
by: Sharma, P, et al.
Published: (2017)

Tackling typhoid fever in South Asia: lessons from Vietnam
by: Basnyat, B, et al.
Published: (2019)

MAGNITUDE OF SCRUB TYPHUS IN ACUTE UNDIFFERENTIATED FEBRILE ILLNESS: A RETROSPECTIVE ANALYSIS OF FIVE YEARS DATA FROM RAJASTHAN, INDIA
by: P. Kumar, et al.
Published: (2023-05-01)

Malaria, sickle cell disease, HIV, and co-trimoxazole prophylaxis: An observational study
by: Ewurama D.A. Owusu, et al.
Published: (2018-04-01)

Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study
by: Giri, A, et al.
Published: (2013)

A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital
by: Zellweger, R, et al.
Published: (2017)

Changing antimicrobial resistance trends in Kathmandu, Nepal: A 23-year retrospective analysis of bacteraemia
by: Zellweger, R, et al.
Published: (2018)

Assessment and Translation of the Antibody-in-Lymphocyte Supernatant (ALS) Assay to Improve the Diagnosis of Enteric Fever in Two Controlled Human Infection Models and an Endemic Area of Nepal
by: Darton, T, et al.
Published: (2017)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
by: Zycinska K, et al.
Published: (2009-12-01)

Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial.
by: Arjyal, A, et al.
Published: (2011)